期刊文献+

辛伐他汀对血压影响的临床观察 被引量:1

Clinical observation about the effect of simvastatin on blood pressure
下载PDF
导出
摘要 目的:观察辛伐他汀对高血压病人血压的影响。方法:42例高血压伴高血脂病人作自身前、后对照,在服用氨氯地平控制血压的基础上,加用辛伐他汀调脂治疗12周。观察用药前、后24小时动态血压的变化。结果: 12周后,患者的总胆固醇、低密度脂蛋白胆固醇和甘油三酯水平显著降低,而高密度脂蛋白胆固醇水平升高不显著。在调脂治疗后血压略有降低,但不显著。结论:辛伐他汀调脂疗效确切,对血压有轻度影响。 Objective: To observe the effect of simvastatin on the blood pressure of patients with hypertension and hypercholesterolemia. Methods: A total of 42 cases were given with simvastatin 20mg, 1/d for 12 weeks after the blood pressures had been decreased to normal range with Amlodipine, the effect of simvastatin on anti-hypertension was assessed with ambulatory blood pressure monitoring (ABPM) for 24 h, the change of their blood pressures were compared with themselves before and after the treatment. Results: After 12 weeks, levels of TC, LDL-C and TG were significantly decreased, however, the elevation of HDL-C was not significant before and after the treatment. The change of blood pressures after the treatment was slight and not significant statistically. The adverse reaction of simvastatin was mild and relatively rare. Conclusion: The simvastatin effected slightly the change of blood pressure in patients with hypertension and hypercholesterolemia, but not significat (P>0.05).
出处 《心血管康复医学杂志》 CAS 2004年第3期235-237,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 辛伐他汀 血压 降脂药 原发性高血压 高胆固醇血症 药物治疗 Simvastatin Blood pressure Effect
  • 相关文献

参考文献9

  • 1刘力生,龚兰生.中国高血压防治指南(试行本)[J].高血压杂志,2000,8(1):94-102. 被引量:945
  • 2[2]The six report of the Joint National Committee on Prevention,detection, evaluation, and treatment of high blood pressure [J].Arch InternMed, 1997, 157 (21): 2413-2446.
  • 3诸骏仁.正确认识合理使用调脂药物[J].中华心血管病杂志,2001,29(12):705-706. 被引量:64
  • 4[5]Omboni S, Parati G, Zanchetti A, et al. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure : methodological aspects [J]. J Hypertens, 1995,13:1105.
  • 5[6]Goode G, Miller J, Heagerty A. Hyperlipidemia, hypertension,and coronary heart disease [J]. Lancet, 1995, 345: 362.
  • 6谭建聪,刘光耀,杨成玉,陈伟.高血压病人血脂与细胞膜离子转运的关系[J].第三军医大学学报,1997,19(4):359-361. 被引量:16
  • 7吴士尧,胡靖超.他汀类药物非降脂作用的再认识[J].国外医学(心血管疾病分册),2003,30(1):5-7. 被引量:32
  • 8[9]Laufs U, La--Fats V, Plutzky J, et al. Up-regulation of endothelial nitric oxide synthase by HMG-COA reductase inhibitors [J]. Circulation. 1998, 97 (12): 1129-1135.
  • 9[10]Brouet A, Sonveaux P, Dessy C, et al. Hspqo and coveolin are key targets for the proangiogenic hitric oxide mediated effects of statins [J]. Circulation Research, 2001, 89 (10): 866-873.

二级参考文献20

  • 1谭建聪,刘光耀.高血压病患者红细胞钠氢离子交换及钙离子内流的变化[J].中华医学杂志,1993,73(12):759-760. 被引量:5
  • 2丁振华,生理科学进展,1994年,25卷,12期,67页
  • 3Chan DC, Watts GF, Barrett PH, et al. Clin Chem, 2001;48(6 Pt 1): 877-883
  • 4Lacoste L, Lam JY, Hung J, et al. Circulation, 1995; 92 (11): 3172-3177
  • 5Puccetti L, Bruni F, Bova G, et al. Nutr Metab CardiovascDis, 2001; 11(6): 378-387
  • 6Chew DP, Bhatt DL, Sapp S, et al. Circulation, 2001; 103 (2): 201-206
  • 7Walter DH, Schachinger V, Elsner M, et al. Eur Heart J, 2001; 22(7): 587-595
  • 8Wagner AH, Kohler T, Ruckschloss U, et al. ArteriosclerThromb Vasc Biol, 2000; 20(1): 61~69
  • 9Laufs U,LiaoJK. J Biol Chem, 1998; 273(37): 24266- 24271
  • 10Matsubara M, Titani K, Taniguchi H. Biochemistry, 1996; 35 (46): 14651- 14658

共引文献1053

同被引文献13

  • 1Vasa M, Fichtlscherer S, Adler k, et al. Increase in circulating endothelial progenitor cells by stain therapy in patients with stable coronary artery disease.Circulation,2001,103 : 2 885-2 890.
  • 2Dimmeler S, Alcher A, Vasa M, et al. HMG-CoA-reductase inhibitors (stains) increase endothelial progenitor cells Via the P13 kinase/Akt pathway. J Clin Invest,2001, 108:391-397.
  • 3Murohara T, Tepper O, Silver M, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol, 2002, 30:967.
  • 4Suzuki T, rqishida M, Futami S, et al. rqeoendothelialization after peripheral blood stem cell transplantation in humans.A case report of a Tokaimura nuclear accident victim.Cardiovasc Res, 2003,58:487-492.
  • 5Kalka C, Masuda H, Takahashi T, et al.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97:3 422-3 427.
  • 6Schatteman GC, Hanlon HP, Jiao C, et al. Blood-derived angioblasts accelerate bloodflow restoration in diabetic mice.J Clin Invest, 2000, 106:571-578.
  • 7Kocber AA,Schuster MD,Szabolcs MJ,et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.Nat Med, 2001, 7:431)-436.
  • 8Dupuis J, Tardif JC, Cernacek P, et al. Cholesterol reduation rapidly improves endothelial function after acute coronary syndromes.The RECIEL ( reduction of cholesterol in ischemia and function of the endothelium) trial.Circulation, 1999, 99:3227-3233.
  • 9Goode G, Miller J, Heagerty A.Hyperlipidemia,hypertension,and coronary heart disease [J], Lancet, 1995, 345:362.
  • 10Heart protection study collaborative group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high risk individuals: randomized placebo-controlledtrial.Lancet, 2002, 360:7-22.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部